Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1079.32%
operating margin TTM
-1147.2%
revenue TTM
27
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.06 |
| peg ratio | 0.00 |
| price to book ratio | -0.16 |
| price to sales ratio | 2.60 |
| enterprise value multiple | -0.28 |
| price fair value | -0.16 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -1147.2% |
| pretax profit margin | -1090.25% |
| net profit margin | -1079.32% |
| return on assets | -124.06% |
| return on equity | 1127.62% |
| return on capital employed | 675.74% |
liquidity ratio | |
|---|---|
| current ratio | 0.24 |
| quick ratio | 0.24 |
| cash ratio | 0.06 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 19.57 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 19.57 |
| receivables turnover | 18.65 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | -0.06 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.07 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -15.11 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.33 |
| cash per share | 0.58 |
| operating cash flow per share | -3.33 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -15.11 |
| short term coverage ratios | -15.11 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Kazia Therapeutics Limited (NASDAQ:KZIA) reported earnings?
Kazia Therapeutics Limited (KZIA) published its most recent earnings results on 31-12-2023.
What is Kazia Therapeutics Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kazia Therapeutics Limited (NASDAQ:KZIA)'s trailing twelve months ROE is 1127.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kazia Therapeutics Limited (KZIA) currently has a ROA of -124.06%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KZIA's net profit margin stand at?
KZIA reported a profit margin of -1079.32% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KZIA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.24 in the most recent quarter. The quick ratio stood at 0.24, with a Debt/Eq ratio of -0.06.